Requirement for cell-to-cell contact in Epstein-Barr virus infection of nasopharyngeal carcinoma cells and keratinocytes.
about
Epstein-Barr virus infection in ex vivo tonsil epithelial cell cultures of asymptomatic carriersPolymeric immunoglobulin receptor polymorphisms and risk of nasopharyngeal cancerCurrent and potential treatments for ubiquitous but neglected herpesvirus infectionsEpstein-Barr Virus: Diseases Linked to Infection and TransformationThe synergistic effect of chemical carcinogens enhances Epstein-Barr virus reactivation and tumor progression of nasopharyngeal carcinoma cellsReactive oxygen species mediate Epstein-Barr virus reactivation by N-methyl-N'-nitro-N-nitrosoguanidineThe Ubiquitin Ligase Itch and Ubiquitination Regulate BFRF1-Mediated Nuclear Envelope Modification for Epstein-Barr Virus Maturation.Infectious Epstein-Barr virus lacking major glycoprotein BLLF1 (gp350/220) demonstrates the existence of additional viral ligands.Regulation of microtubule dynamics through phosphorylation on stathmin by Epstein-Barr virus kinase BGLF4Uracil DNA glycosylase BKRF3 contributes to Epstein-Barr virus DNA replication through physical interactions with proteins in viral DNA replication complex.Lytic viral replication as a contributor to the detection of Epstein-Barr virus in breast cancerEpstein-Barr virus BGLF4 kinase retards cellular S-phase progression and induces chromosomal abnormality.The ESCRT machinery is recruited by the viral BFRF1 protein to the nucleus-associated membrane for the maturation of Epstein-Barr Virus.Interplay between PKCδ and Sp1 on histone deacetylase inhibitor-mediated Epstein-Barr virus reactivation.BGLF4 kinase modulates the structure and transport preference of the nuclear pore complex to facilitate nuclear import of Epstein-Barr virus lytic proteinsInduction of the early growth response 1 gene by Epstein-Barr virus lytic transactivator Zta.Ran GTPase-activating protein 1 is a therapeutic target in diffuse large B-cell lymphoma.Epstein-Barr virus Zta-induced immunomodulators from nasopharyngeal carcinoma cells upregulate interleukin-10 production from monocytesNeuropilin 1 is an entry factor that promotes EBV infection of nasopharyngeal epithelial cellsEGCG inhibits proliferation, invasiveness and tumor growth by up-regulation of adhesion molecules, suppression of gelatinases activity, and induction of apoptosis in nasopharyngeal carcinoma cells.Analysis of Epstein-Barr virus reservoirs in paired blood and breast cancer primary biopsy specimens by real time PCR.Characterization of the uracil-DNA glycosylase activity of Epstein-Barr virus BKRF3 and its role in lytic viral DNA replication.Role of the TSG101 gene in Epstein-Barr virus late gene transcription.Epstein-Barr virus BGLF4 kinase induces premature chromosome condensation through activation of condensin and topoisomerase II.Dysregulation of HER2/HER3 signaling axis in Epstein-Barr virus-infected breast carcinoma cells.Epstein-Barr Virus Infection in Gastric Remnant Carcinoma and Recurrent Gastric Carcinoma in Qingdao of Northern ChinaEpstein-Barr virus protein kinase BGLF4 targets the nucleus through interaction with nucleoporins.Epstein-Barr virus BGLF4 kinase downregulates NF-κB transactivation through phosphorylation of coactivator UXT.Epstein-Barr virus lytic transactivator Zta enhances chemotactic activity through induction of interleukin-8 in nasopharyngeal carcinoma cells.Critical role of p53 in histone deacetylase inhibitor-induced Epstein-Barr virus Zta expressionEpstein-Barr virus BGLF4 kinase induces disassembly of the nuclear lamina to facilitate virion productionEpstein-Barr virus BGLF4 kinase suppresses the interferon regulatory factor 3 signaling pathwayEBV reactivation as a target of luteolin to repress NPC tumorigenesis.EBV BMRF-2 facilitates cell-to-cell spread of virus within polarized oral epithelial cells.Inhibition of Epstein-Barr virus reactivation by the flavonoid apigenin.Induction of Epstein-Barr virus latent membrane protein 1 by a lytic transactivator Rta.Epstein-Barr virus BALF3 has nuclease activity and mediates mature virion production during the lytic cycle.Epstein-Barr Virus (EBV)-associated gastric carcinoma.De novo infection of B cells during murine gammaherpesvirus 68 latencyElimination of LMP1-expressing cells from a monolayer of gastric cancer AGS cells
P2860
Q24561854-1390BC5E-3E2E-439E-80A3-78914CCA58C6Q24798529-E4769FD9-A06C-4C24-B393-E73145F54A3EQ27023452-8B9686A2-E38C-4ED6-B6DC-F586D8E54D61Q28074586-DA98CB14-41FE-4B6B-BFF1-BD23EFC7F8CBQ28483778-CEC5BA63-DBF4-4D12-AA32-6503A77766FAQ28537881-B4E1AFF1-ACC4-488F-90FB-46EA24F26BF5Q30817391-F451603A-8354-445E-8812-9F9D1ED04DDBQ33603682-9FA41CC8-353C-47D7-A0E9-14EAEFC1A280Q33744412-E61802FE-4249-4209-AE89-B9301C684D73Q34059171-B510ACA6-DBEE-4759-9698-E54AFA047677Q34226611-11F04FEF-E57A-4A35-B0DE-7547DAAF14B1Q34328083-D312D2A1-5C9A-4FC9-9190-4C7CAAE6447BQ34411847-B1BAA7B2-43CB-4FF8-9F7C-2A74DCCFDA89Q34741684-EC4F8A3E-1854-4A7D-A5DE-AAACE26A93ADQ34991450-FA694DDC-D10B-4DFE-A691-41602D4166BFQ35023745-3F448E2C-E0C8-4345-BC7A-68BBCF5BEAA6Q35040346-08385BDC-76FF-4C9C-B3E9-38941ECEAE7EQ35077651-DA58D5F7-D35A-4DB9-A654-8644B3168D26Q35119824-6C1AE793-E70E-4F96-AFAE-FE1F68466E04Q35138905-A9986B5F-06E9-4171-A385-49962B9BAA3EQ35633651-FED30024-6FAF-4CE4-843C-D565F80DCF66Q35635277-38022C8F-5F42-493C-B466-AED2B9E0800AQ35784756-25CB39A5-4E2E-4AC9-BF9E-C4D3B890A671Q35857467-A9FFACBE-9EA5-4660-880A-064F147F79C8Q35857669-F8DB5024-1BAB-41AF-9401-9D72B59A582DQ35918250-05B39933-4045-4C72-A994-454FB6B97CD6Q36171843-B24810CD-F871-45B8-9D04-2264BB4A0853Q36363901-87493365-EF43-4220-9161-261B2C9B0F3EQ36498181-7F0ADA52-BC8B-4A29-849C-5556334E91D9Q36804608-0037D019-FFD6-4E2A-88C8-AAD67D34478EQ36974656-CC60BC61-15B6-4481-861E-D62BE748381FQ37099766-6D48D871-B576-4DBD-8091-FAD945A3FDB4Q37109915-782AA885-5EE9-41FF-9DFB-2FF997DAE639Q37303761-80FFCC79-8D7F-4C45-8C93-93F0787E6341Q37566280-DFD8E6E3-D95C-443E-830D-F1AF581BFB82Q37596540-283B9943-E4B3-43F7-B2BB-EE4257679173Q37714026-CE90CF31-8AA4-4764-81A3-F3CA3C98088EQ38076138-73BC83B9-B83F-4ECE-ACC0-0AF9D6484951Q38631870-44EFC1F6-3953-49E3-A95E-71A157E64094Q38705672-46084517-7701-444E-B744-D804B4C3EB9D
P2860
Requirement for cell-to-cell contact in Epstein-Barr virus infection of nasopharyngeal carcinoma cells and keratinocytes.
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Requirement for cell-to-cell c ...... inoma cells and keratinocytes.
@ast
Requirement for cell-to-cell c ...... inoma cells and keratinocytes.
@en
type
label
Requirement for cell-to-cell c ...... inoma cells and keratinocytes.
@ast
Requirement for cell-to-cell c ...... inoma cells and keratinocytes.
@en
prefLabel
Requirement for cell-to-cell c ...... inoma cells and keratinocytes.
@ast
Requirement for cell-to-cell c ...... inoma cells and keratinocytes.
@en
P2093
P2860
P1433
P1476
Requirement for cell-to-cell c ...... cinoma cells and keratinocytes
@en
P2093
P2860
P304
P577
1999-10-01T00:00:00Z